MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications during hospital stays can cause confusion and lead to missed doses or incorrect use. This is especially common in communities with limited access to healthcare.

The study uses a computer-based tool called MEDBRIDGE (MEDication BRIDGE) to identify patients who may be at higher risk for problems after discharge, such as worsening blood sugar control or return visits to the emergency department. Patients identified as high-risk will receive 3 months of support from a nurse case manager and community health worker team, who will help with medication questions, coordinate with their doctor, and provide follow-up check-ins.

The main goal is to find out whether this type of support program is practical to deliver and acceptable to patients. The study will also track changes in blood sugar levels and emergency department visits. Forty-five patients will be enrolled over 6 months at the University of Alabama at Birmingham and Cooper Green Mercy Health Services in Jefferson County, Alabama.

Eligibility criteria

Qualifiers

Adults aged 18 years or older

Diagnosis of type 2 diabetes (HbA1c of 6.5% or higher or relevant ICD-10 codes including E11, E13, E14, R73, L97.509, K31.84)

Discharged from UAB Hospital or its emergency departments

Receiving primary care at Cooper Green Mercy Health Services or UAB Post Discharge Clinic

Disqualifiers

Under age 18

No indication of type 2 diabetes

Not affiliated with Cooper Green Mercy Health Services or UAB Post Discharge Clinic for primary care

Unable to provide informed consent

Trial design

Treatments tested in this trial

  • MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention

Treatment groups

45 Participants
are divided into 1 treatment group